Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Perifosine inhibits mammalian target of rapamycin signaling through facilitating degradation of major components in the mTOR axis and induces autophagy.

Identifieur interne : 001777 ( Main/Exploration ); précédent : 001776; suivant : 001778

Perifosine inhibits mammalian target of rapamycin signaling through facilitating degradation of major components in the mTOR axis and induces autophagy.

Auteurs : Lei Fu [États-Unis] ; Young-Ae Kim ; Xuerong Wang ; Xiaoyun Wu ; Ping Yue ; Sagar Lonial ; Fadlo R. Khuri ; Shi-Yong Sun

Source :

RBID : pubmed:19920197

Descripteurs français

English descriptors

Abstract

Perifosine is an alkylphospholipid exhibiting antitumor activity as shown in both preclinical studies and clinical trials. This activity is partly associated with its ability to inhibit Akt activity. It has been shown that the mammalian target of rapamycin (mTOR) axis plays a critical role in regulation of cell proliferation and survival primarily through functioning both downstream and upstream of Akt. The current study reveals a novel mechanism by which perifosine inhibits Akt and the mTOR axis. In addition to inhibition of Akt, perifosine inhibited the assembly of both mTOR/raptor and mTOR/rictor complexes. Strikingly, perifosine reduced the levels of Akt and other major components including mTOR, raptor, rictor, 70-kDa ribosomal S6 kinase, and 4E-binding protein 1 in the mTOR axis by promoting their degradation through a GSK3/FBW7-dependent mechanism. These results thus suggest that perifosine inhibits the mTOR axis through a different mechanism from inhibition of mTOR signaling by classic mTOR inhibitors such as rapamycin. Moreover, perifosine substantially increased the levels of type II light chain 3, a hallmark of autophagy, in addition to increasing poly(ADP-ribose) polymerase cleavage, suggesting that perifosine induces both apoptosis and autophagy. The combination of perifosine with a lysosomal inhibitor enhanced apoptosis and inhibited the growth of xenografts in nude mice, suggesting that perifosine-induced autophagy protects cells from undergoing apoptosis. Collectively, we conclude that perifosine inhibits mTOR signaling and induces autophagy, highlighting a novel mechanism accounting for the anticancer activity of perifosine and a potential strategy to enhance the anticancer efficacy of perifosine by preventing autophagy.

DOI: 10.1158/0008-5472.CAN-09-2190
PubMed: 19920197


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Perifosine inhibits mammalian target of rapamycin signaling through facilitating degradation of major components in the mTOR axis and induces autophagy.</title>
<author>
<name sortKey="Fu, Lei" sort="Fu, Lei" uniqKey="Fu L" first="Lei" last="Fu">Lei Fu</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Hematology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia 30322, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Hematology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia 30322</wicri:regionArea>
<wicri:noRegion>Georgia 30322</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kim, Young Ae" sort="Kim, Young Ae" uniqKey="Kim Y" first="Young-Ae" last="Kim">Young-Ae Kim</name>
</author>
<author>
<name sortKey="Wang, Xuerong" sort="Wang, Xuerong" uniqKey="Wang X" first="Xuerong" last="Wang">Xuerong Wang</name>
</author>
<author>
<name sortKey="Wu, Xiaoyun" sort="Wu, Xiaoyun" uniqKey="Wu X" first="Xiaoyun" last="Wu">Xiaoyun Wu</name>
</author>
<author>
<name sortKey="Yue, Ping" sort="Yue, Ping" uniqKey="Yue P" first="Ping" last="Yue">Ping Yue</name>
</author>
<author>
<name sortKey="Lonial, Sagar" sort="Lonial, Sagar" uniqKey="Lonial S" first="Sagar" last="Lonial">Sagar Lonial</name>
</author>
<author>
<name sortKey="Khuri, Fadlo R" sort="Khuri, Fadlo R" uniqKey="Khuri F" first="Fadlo R" last="Khuri">Fadlo R. Khuri</name>
</author>
<author>
<name sortKey="Sun, Shi Yong" sort="Sun, Shi Yong" uniqKey="Sun S" first="Shi-Yong" last="Sun">Shi-Yong Sun</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2009">2009</date>
<idno type="RBID">pubmed:19920197</idno>
<idno type="pmid">19920197</idno>
<idno type="doi">10.1158/0008-5472.CAN-09-2190</idno>
<idno type="wicri:Area/PubMed/Corpus">000405</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000405</idno>
<idno type="wicri:Area/PubMed/Curation">000405</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000405</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000396</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000396</idno>
<idno type="wicri:Area/Ncbi/Merge">000126</idno>
<idno type="wicri:Area/Ncbi/Curation">000126</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000126</idno>
<idno type="wicri:Area/Main/Merge">001781</idno>
<idno type="wicri:Area/Main/Curation">001777</idno>
<idno type="wicri:Area/Main/Exploration">001777</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Perifosine inhibits mammalian target of rapamycin signaling through facilitating degradation of major components in the mTOR axis and induces autophagy.</title>
<author>
<name sortKey="Fu, Lei" sort="Fu, Lei" uniqKey="Fu L" first="Lei" last="Fu">Lei Fu</name>
<affiliation wicri:level="1">
<nlm:affiliation>Department of Hematology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia 30322, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Hematology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia 30322</wicri:regionArea>
<wicri:noRegion>Georgia 30322</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Kim, Young Ae" sort="Kim, Young Ae" uniqKey="Kim Y" first="Young-Ae" last="Kim">Young-Ae Kim</name>
</author>
<author>
<name sortKey="Wang, Xuerong" sort="Wang, Xuerong" uniqKey="Wang X" first="Xuerong" last="Wang">Xuerong Wang</name>
</author>
<author>
<name sortKey="Wu, Xiaoyun" sort="Wu, Xiaoyun" uniqKey="Wu X" first="Xiaoyun" last="Wu">Xiaoyun Wu</name>
</author>
<author>
<name sortKey="Yue, Ping" sort="Yue, Ping" uniqKey="Yue P" first="Ping" last="Yue">Ping Yue</name>
</author>
<author>
<name sortKey="Lonial, Sagar" sort="Lonial, Sagar" uniqKey="Lonial S" first="Sagar" last="Lonial">Sagar Lonial</name>
</author>
<author>
<name sortKey="Khuri, Fadlo R" sort="Khuri, Fadlo R" uniqKey="Khuri F" first="Fadlo R" last="Khuri">Fadlo R. Khuri</name>
</author>
<author>
<name sortKey="Sun, Shi Yong" sort="Sun, Shi Yong" uniqKey="Sun S" first="Shi-Yong" last="Sun">Shi-Yong Sun</name>
</author>
</analytic>
<series>
<title level="j">Cancer research</title>
<idno type="eISSN">1538-7445</idno>
<imprint>
<date when="2009" type="published">2009</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Autophagy (drug effects)</term>
<term>Cell Cycle Proteins (metabolism)</term>
<term>Cell Line, Tumor</term>
<term>Chloroquine (pharmacology)</term>
<term>F-Box Proteins (metabolism)</term>
<term>F-Box-WD Repeat-Containing Protein 7</term>
<term>Female</term>
<term>Glycogen Synthase Kinase 3 (metabolism)</term>
<term>HCT116 Cells</term>
<term>Humans</term>
<term>Lung Neoplasms (drug therapy)</term>
<term>Lung Neoplasms (metabolism)</term>
<term>Lung Neoplasms (pathology)</term>
<term>Mice</term>
<term>Mice, Nude</term>
<term>Oncogene Protein v-akt (metabolism)</term>
<term>Phosphorylation (drug effects)</term>
<term>Phosphorylcholine (analogs & derivatives)</term>
<term>Phosphorylcholine (pharmacology)</term>
<term>Protein Kinases (metabolism)</term>
<term>Signal Transduction (drug effects)</term>
<term>TOR Serine-Threonine Kinases</term>
<term>Ubiquitin-Protein Ligases (metabolism)</term>
<term>Xenograft Model Antitumor Assays</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Autophagie ()</term>
<term>Cellules HCT116</term>
<term>Chloroquine (pharmacologie)</term>
<term>Femelle</term>
<term>Glycogen Synthase Kinase 3 (métabolisme)</term>
<term>Humains</term>
<term>Lignée cellulaire tumorale</term>
<term>Phosphoryl-choline (analogues et dérivés)</term>
<term>Phosphoryl-choline (pharmacologie)</term>
<term>Phosphorylation ()</term>
<term>Protein kinases (métabolisme)</term>
<term>Protéine oncogène v-akt (métabolisme)</term>
<term>Protéines F-box (métabolisme)</term>
<term>Protéines du cycle cellulaire (métabolisme)</term>
<term>Souris</term>
<term>Souris nude</term>
<term>Sérine-thréonine kinases TOR</term>
<term>Tests d'activité antitumorale sur modèle de xénogreffe</term>
<term>Transduction du signal ()</term>
<term>Tumeurs du poumon (anatomopathologie)</term>
<term>Tumeurs du poumon (métabolisme)</term>
<term>Tumeurs du poumon (traitement médicamenteux)</term>
<term>Ubiquitin-protein ligases (métabolisme)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en">
<term>Phosphorylcholine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Cell Cycle Proteins</term>
<term>F-Box Proteins</term>
<term>Glycogen Synthase Kinase 3</term>
<term>Oncogene Protein v-akt</term>
<term>Protein Kinases</term>
<term>Ubiquitin-Protein Ligases</term>
</keywords>
<keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr">
<term>Phosphoryl-choline</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Tumeurs du poumon</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Autophagy</term>
<term>Phosphorylation</term>
<term>Signal Transduction</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Lung Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Lung Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Glycogen Synthase Kinase 3</term>
<term>Protein kinases</term>
<term>Protéine oncogène v-akt</term>
<term>Protéines F-box</term>
<term>Protéines du cycle cellulaire</term>
<term>Tumeurs du poumon</term>
<term>Ubiquitin-protein ligases</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Lung Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Chloroquine</term>
<term>Phosphoryl-choline</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Chloroquine</term>
<term>Phosphorylcholine</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Tumeurs du poumon</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Cell Line, Tumor</term>
<term>F-Box-WD Repeat-Containing Protein 7</term>
<term>Female</term>
<term>HCT116 Cells</term>
<term>Humans</term>
<term>Mice</term>
<term>Mice, Nude</term>
<term>TOR Serine-Threonine Kinases</term>
<term>Xenograft Model Antitumor Assays</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Autophagie</term>
<term>Cellules HCT116</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lignée cellulaire tumorale</term>
<term>Phosphorylation</term>
<term>Souris</term>
<term>Souris nude</term>
<term>Sérine-thréonine kinases TOR</term>
<term>Tests d'activité antitumorale sur modèle de xénogreffe</term>
<term>Transduction du signal</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Perifosine is an alkylphospholipid exhibiting antitumor activity as shown in both preclinical studies and clinical trials. This activity is partly associated with its ability to inhibit Akt activity. It has been shown that the mammalian target of rapamycin (mTOR) axis plays a critical role in regulation of cell proliferation and survival primarily through functioning both downstream and upstream of Akt. The current study reveals a novel mechanism by which perifosine inhibits Akt and the mTOR axis. In addition to inhibition of Akt, perifosine inhibited the assembly of both mTOR/raptor and mTOR/rictor complexes. Strikingly, perifosine reduced the levels of Akt and other major components including mTOR, raptor, rictor, 70-kDa ribosomal S6 kinase, and 4E-binding protein 1 in the mTOR axis by promoting their degradation through a GSK3/FBW7-dependent mechanism. These results thus suggest that perifosine inhibits the mTOR axis through a different mechanism from inhibition of mTOR signaling by classic mTOR inhibitors such as rapamycin. Moreover, perifosine substantially increased the levels of type II light chain 3, a hallmark of autophagy, in addition to increasing poly(ADP-ribose) polymerase cleavage, suggesting that perifosine induces both apoptosis and autophagy. The combination of perifosine with a lysosomal inhibitor enhanced apoptosis and inhibited the growth of xenografts in nude mice, suggesting that perifosine-induced autophagy protects cells from undergoing apoptosis. Collectively, we conclude that perifosine inhibits mTOR signaling and induces autophagy, highlighting a novel mechanism accounting for the anticancer activity of perifosine and a potential strategy to enhance the anticancer efficacy of perifosine by preventing autophagy.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Khuri, Fadlo R" sort="Khuri, Fadlo R" uniqKey="Khuri F" first="Fadlo R" last="Khuri">Fadlo R. Khuri</name>
<name sortKey="Kim, Young Ae" sort="Kim, Young Ae" uniqKey="Kim Y" first="Young-Ae" last="Kim">Young-Ae Kim</name>
<name sortKey="Lonial, Sagar" sort="Lonial, Sagar" uniqKey="Lonial S" first="Sagar" last="Lonial">Sagar Lonial</name>
<name sortKey="Sun, Shi Yong" sort="Sun, Shi Yong" uniqKey="Sun S" first="Shi-Yong" last="Sun">Shi-Yong Sun</name>
<name sortKey="Wang, Xuerong" sort="Wang, Xuerong" uniqKey="Wang X" first="Xuerong" last="Wang">Xuerong Wang</name>
<name sortKey="Wu, Xiaoyun" sort="Wu, Xiaoyun" uniqKey="Wu X" first="Xiaoyun" last="Wu">Xiaoyun Wu</name>
<name sortKey="Yue, Ping" sort="Yue, Ping" uniqKey="Yue P" first="Ping" last="Yue">Ping Yue</name>
</noCountry>
<country name="États-Unis">
<noRegion>
<name sortKey="Fu, Lei" sort="Fu, Lei" uniqKey="Fu L" first="Lei" last="Fu">Lei Fu</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001777 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001777 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:19920197
   |texte=   Perifosine inhibits mammalian target of rapamycin signaling through facilitating degradation of major components in the mTOR axis and induces autophagy.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:19920197" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a ChloroquineV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021